[DHR] Danaher Corporation


Type of security: Stock

Sector: Capital Goods

Industry: Industrial Machinery/Components

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 78.94 Change: 0.61 (0.78%)
Ext. hours: Change: 0 (0%)

chart DHR

Refresh chart

Strongest Trends Summary For DHR

DHR is in the medium-term down -8% below S&P in 1 year. In the long-term up 37% in 2 years and up 534% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company?s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; network monitoring, management, and optimization tools; and security solutions for communications and enterprise networks. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company?s Life Sciences & Diagnostics segment provides various research and clinical tools for scientists to study cells and its components; and a range of analytical instruments, reagents, consumables, software, and services for hospitals, physician?s offices, reference laboratories

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters-1.72% EPS Growth - Q/Q20.16%
EPS Growth - Y/Y-10.3% Sales Growth - 4 Quarters 5.27% Sales Growth - Q/Q5.21% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA7.05% ROE10.82% ROI8.18%
Current Ratio1.91 Quick Ratio1.53 Long Term Debt/Equity0.66 Debt Ratio0.21
Gross Margin52.89% Operating Margin17.05% Net Profit Margin12.85% Dividend Payout Ratio-11.74%
Dividend Yield
Fundamental Data
Cash From Financing Activities-299.4 M Cash From Investing Activities-937.6 M Cash From Operating Activities1.62 B Gross Profit2.76 B
Net Profit695.6 M Operating Profit931.1 M Total Assets36.99 B Total Current Assets9.65 B
Total Current Liabilities5.06 B Total Debt3.16 B Total Liabilities12.89 B Total Revenue5.13 B
Technical Data
High 52 week146.3 Low 52 week94.58 Last close137.59 Last change-0.87%
RSI38.73 Average true range3.27 Beta0.9 Volume1.17 M
Simple moving average 20 days-2.52% Simple moving average 50 days-1.89% Simple moving average 200 days5.44%
Performance Data
Performance Week1.45% Performance Month-2.06% Performance Quart-1.36% Performance Half7.47%
Performance Year33.3% Performance Year-to-date33.6% Volatility daily1.48% Volatility weekly3.31%
Volatility monthly6.78% Volatility yearly23.49% Relative Volume230.45% Average Volume2.2 M
New High New Low


2020-05-29 09:44:18 | How This Week Highlights the Challenges Facing General Electric Stock

2020-05-28 12:06:00 | FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test

2020-05-26 14:04:42 | Hedge Funds Have Never Been This Bullish On Danaher Corporation DHR

2020-05-19 10:57:11 | Danaher Luxembourg Finance S.a.r.l. -- Moody's announces completion of a periodic review of ratings of Danaher Corporation

2020-05-18 11:49:00 | Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market

2020-05-18 11:28:48 | A Trio of Strong Performers to Consider

2020-05-16 09:15:00 | Merck, Medtronic, and Other Health-Care Stocks Widely Owned by ESG Funds Outperform

2020-05-15 08:18:00 | Is Danaher Stock a Buy?

2020-05-14 17:02:00 | GE Stock Dropped Again. But Here’s What Is Going Right.

2020-05-14 07:40:11 | Danaher's Stock Offering Proceeds to Fund Corporate Needs

2020-05-12 16:10:00 | Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

2020-05-12 11:51:00 | Jefferies Picks 20 Global Health-Care Winners for a Post-Pandemic World

2020-05-08 18:35:53 | 8 Stocks Ken Fisher Continues to Buy

2020-05-08 01:15:00 | Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

2020-05-07 18:00:36 | Danaher Corp DHR Q1 2020 Earnings Call Transcript

2020-05-07 16:11:47 | Edited Transcript of DHR earnings conference call or presentation 7-May-20 11:30am GMT

2020-05-07 09:55:01 | Danaher DHR Beats Q1 Earnings Estimates, Provides Bleak View

2020-05-07 08:52:00 | Danaher's stock drops after launching offerings of $2.5 billion in equity securities

2020-05-07 08:40:00 | Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

2020-05-07 04:46:25 | Stocks - Peloton, PayPal Surge in Premarket on Boost From Lockdowns

2020-05-06 18:05:10 | Danaher DHR Q1 Earnings Top Estimates

2020-05-06 16:10:00 | Danaher Reports First Quarter 2020 Results

2020-05-06 16:10:00 | Danaher Corporation Announces CEO Transition

2020-05-06 10:52:02 | Is a Surprise Coming for Danaher DHR This Earnings Season?

2020-05-05 16:10:00 | Danaher Announces Quarterly Dividend

2020-05-05 10:06:02 | Danaher DHR to Report Q1 Earnings: Is a Beat in Store?

2020-05-04 11:01:03 | Timing the Market, Is it Possible? - May 04, 2020

2020-05-04 08:55:00 | Why Danaher Stock Soared in April

2020-05-01 12:29:46 | Earnings Highlight the Long Road Ahead for General Electric Stock

2020-04-30 12:33:04 | Danaher DHR Expected to Beat Earnings Estimates: Should You Buy?

2020-04-30 12:10:04 | Can Danaher DHR Keep the Earnings Surprise Streak Alive?

2020-04-30 09:00:00 | Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition

2020-04-29 12:30:00 | GE Stock Nears Lowest Point in Years as Pandemic Hits Home

2020-04-23 17:48:08 | Were Hedge Funds Right About Danaher Corporation DHR?

2020-04-17 11:03:57 | Steer Clear of Co-Diagnostics Stock and Its Multitude of Red Flags

2020-04-15 09:04:01 | Healthy Business to Aid Danaher in Q1 Despite Coronavirus Woes

2020-04-14 09:38:01 | Danaher Gives Update on Q1 Results, Withdraws 2020 Guidance

2020-04-13 09:46:41 | GE cuts some debt using proceeds from sale of biopharma business

2020-04-13 07:40:00 | Danaher Sees First-Quarter Revenue Gain of 3%, Withdraws Fiscal-Year Guidance

2020-04-13 06:56:00 | Danaher sees April quarter revenue growth of about 3%, withdraws 2020 guidance

2020-04-13 06:45:00 | Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call

2020-04-13 05:14:00 | Danaher Expects Weak Q1 and Pulls Guidance on COVID-19 Uncertainty; Shares Mildly Overvalued

2020-04-10 14:41:08 | Danaher raises millions to pay down debts, just days after closing $21.4B GE deal

2020-04-09 12:30:04 | Analysts Estimate Danaher DHR to Report a Decline in Earnings: What to Look Out for

2020-04-09 06:00:00 | Roche and Danaher- Two Plays on Testing

2020-04-06 14:16:00 | GE Might Have to Sell More Stock. Then Again, Maybe Not.

2020-04-06 08:57:12 | Danaher DHR Prices Senior Notes Offering Worth Euro 750M

2020-04-03 16:45:00 | Danaher Prices Reopening Of Euro-Denominated Senior Notes

2020-04-03 12:05:46 | Why GE Stock Still Looks Like a Good Play for Long-Term Investors

2020-04-02 02:43:39 | General Electric Closes $21.4 Billion Biopharma Sale to Danaher